RxDoctor Payments Data

Austin Kramer, DPM

Podiatrist · Fayetteville, ARNPI 1902239486

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.6% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Organogenesis Inc. at 30.8% of the total.

$1,492in general payments, 2019–2025

Across 75 payments — averaging $19.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$460
  • Amgen$304
  • Stryker$191
  • Paratek Pharmaceuticals, Inc.$101
  • Treace Medical Concepts, Inc.$75
  • Johnson & Johnson$74
  • plus $287 from 11 others

What the payments were for

  • Food & beverage$1,487100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Organogenesis Inc.20$460
Amgen(2 entities)22$304
Stryker7$191
Paratek Pharmaceuticals, Inc.5$101
Treace Medical Concepts, Inc.2$75
Johnson & Johnson3$74
Bioventus LLC4$62
Biowound Solutions, Inc.2$41
Kerecis Limited2$32
Smith+Nephew1$24
Polynovo North America LLC1$21
AbbVie1$20
Alfasigma USA, Inc.1$19
ANI Pharmaceuticals, Inc.1$19
Philips North America LLC1$18
Triad Life Sciences Inc.1$16
Zyla Life Sciences, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,492 in reported general payments places this provider in the 60th percentile of 35 podiatrist providers in Arkansas.

See all podiatrist providers in Arkansas

Medicare billing

Part B allowed, 2024
$641,771
Medicare patients
479
Services billed
4,743

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole20$300
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav20$288
Terbinafine Hcl18$184
Gabapentin19$160
Mupirocin24$160
Cephalexin25$132
Ibuprofen12$130
Famotidine11$115
SsdSilver Sulfadiazine18$111
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$90
Methylprednisolone15$84
Silver Sulfadiazine11$84

Paid to pharmacies, not to this prescriber.

Other podiatrist in Fayetteville

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →